Our joint working arrangement with Sanofi is helping to improve identification of people with Familial Hypocholesterolaemia (FH).
FH is an inherited genetic condition that results in some people having exceptionally high levels of cholesterol in their blood and increases their risk of developing chronic heart disease.
One in every 500 people in the UK (around 100,000 people) are believed to have FH but only 10-15 per cent of them have been identified and receiving treatment. Left untreated, it is estimated that 50 per cent of men and 30 per cent of women with FH will have developed chronic heart disease by the age of 50.
The NHS England Long Term Plan aims to increase the number of people identified with FH from seven to at least 25 per cent over the next five years.
We are currently working with Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield CCG, Hull and East Yorkshire Hospitals NHS Trust and North East Lincolnshire CCGs to:
- Improve the identification of patients with suspected FH
- Provide more specialist care within GP practice
- Increase the level of appropriate referrals to the specialist service to ensure patients receive appropriate treatment and genetic testing
For more information about the programme please contact us